Healthy Eating for Colon Cancer Prevention

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT00475722
Collaborator
(none)
120
1
2
55
2.2

Study Details

Study Description

Brief Summary

The purpose of this study is to help develop diets for colon cancer prevention. This study will compare the Mediterranean diet to the Healthy People 2010 diet in 120 subjects with increased risk for colorectal cancer.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: 1 Healthy Eating
  • Behavioral: 2 Mediterranean
N/A

Detailed Description

There is substantial epidemiological evidence that dietary patterns influence colorectal cancer risk. The associations of any particular nutrient with increased or decreased risks, however, may not be due to that nutrient per se but to the whole foods that are rich in that nutrient. Simultaneously, reducing intakes of foods associated with increased risk while increasing foods identified in preventive diets may be the best approach for prevention. The Cretan-Mediterranean diet in particular appears to hold great promise for cancer prevention. The major components of the traditional Cretan diet have been associated with decreased colon cancer. Relative to the American diet, this diet has lower n-6/n-3 and n-6/n-9 fatty acid ratios, lower polyunsaturated fatty acid intake, lower red meat intake, and higher intakes of plant-based foods and monounsaturated fatty acids.

The hypothesis of this study is that adherence to a Mediterranean type of diet will result in a decrease in n-6 fatty acids and increased n-3 and n-9 fatty acids in human colorectal mucosa. This together with aspects of the diet such as increased intakes of fruits and vegetables, is expected to modulate eicosanoid metabolism and epithelial proliferation in normal mucosa. 120 persons, with an increased risk for colorectal cancer, will be randomized to a modified Mediterranean diet or a Healthy People 2010 diet for six months.

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
A Mediterranean Diet in Colon Cancer Prevention
Study Start Date :
May 1, 2007
Actual Primary Completion Date :
Nov 1, 2010
Actual Study Completion Date :
Dec 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1 Healthy Eating

Healthy People 2010 Diet using an exchange list

Behavioral: 1 Healthy Eating
6 months telephone counseling

Experimental: 2 Mediterranean

Mediterranean Diet using an exchange list

Behavioral: 2 Mediterranean
6 months telephone counseling

Outcome Measures

Primary Outcome Measures

  1. Adherence to Dietary Goals [6 months]

    Percentage of participants who met 70% of diet goals as outlined in the exchange list

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Prior adenomatous polyp.

  • Prior resected early (Dukes A, B, or C) colon cancer. With the exception of curative surgery for small lesions, such as endoscopically removed cancers, eligible subject will be at least two years post treatment for colorectal cancer.

  • A history of colon cancer in a primary relative or in two secondary relatives.

  • Good general health and not expecting major lifestyle changes in the next 6 months.

  • Age 21 or older.

  • Not expecting a change in hormonal therapies over the next 6 months.

  • Taking less than 81 mg/day or 325 mg aspirin every other day for prevention of cardiovascular disease.

  • Dietary intake that is within the usual range for a typical American diet.

  • Read and understand English.

  • Sign the consent and willing to comply with all study procedures.

  • Have a telephone.

  • At least 5 years post any type of treatment for any other cancer except cancers that were removed completely by surgery and no other treatment was undergone.

  • No more than occasional use (< 25% of the time) of pain medications and willing to take only regular strength acetaminophen while on study except for 81 mg/day or 325 mg every other day of aspirin for prevention of cardiovascular disease.

Exclusion Criteria:
  • On medically prescribed diets or following a diet that would require extensive counseling to correct nutritional deficiencies.

  • Taking supplements or medications that might obscure our ability to detect an effect of diet (eg. lipid-lowering medications, insulin, fish oils, mega-vitamins).

  • Are pregnant or lactating or planning to get pregnant.

  • Previous diagnosis of HIV or hepatitis C.

  • Have cancer at the present time.

  • Being treated with or taking therapies or supplements that could obscure our ability to detect diet effects, such as fish oils.

  • Previous advanced cancer (Duke's D) or hereditary and familial polyposis (HNPCC/FAP) because the latter are rare conditions with unique etiology.

  • Due to the effects of inflammation on biomarker levels in mucosa, persons with Crohn's disease or inflammatory bowel disease will be excluded.

  • Persons with BMI < 18.5 or > 35 kg/m2 since low BMI could indicate eating disorders and high BMI values, above the midpoint of the obesity range, could indicate more prevalent health problems and these persons can be more difficult to counsel.

  • Persons taking very high levels of aspirin or non-steroidal anti-inflammatory agents (NSAIDS) for conditions such as arthritis, a chronic inflammatory condition, will be excluded since it will preclude our ability to detect a further decrease in PGE2.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan

Investigators

  • Principal Investigator: Zora Djuric, Ph.D., University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zora Djuric, Research Professor, University of Michigan
ClinicalTrials.gov Identifier:
NCT00475722
Other Study ID Numbers:
  • HUM00007622
First Posted:
May 21, 2007
Last Update Posted:
Sep 26, 2016
Last Verified:
Aug 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Zora Djuric, Research Professor, University of Michigan
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title 1 Healthy Eating 2 Mediterranean
Arm/Group Description Healthy People 2010 Diet Healthy People 2010 Diet through dietary counseling: 6 months telephone counseling Mediterranean Diet Mediterranean Diet through dietary counseling: 6 months telephone counseling
Period Title: Overall Study
STARTED 61 59
COMPLETED 46 47
NOT COMPLETED 15 12

Baseline Characteristics

Arm/Group Title 1 Healthy Eating 2 Mediterranean Total
Arm/Group Description Healthy People 2010 Diet using an exchange list 1 Healthy Eating: 6 months telephone counseling Mediterranean Diet using an exchange list 2 Mediterranean: 6 months telephone counseling Total of all reporting groups
Overall Participants 61 59 120
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
51
(13)
55
(10)
53
(12)
Sex: Female, Male (Count of Participants)
Female
43
70.5%
43
72.9%
86
71.7%
Male
18
29.5%
16
27.1%
34
28.3%
Ethnicity (NIH/OMB) (Count of Participants)
Hispanic or Latino
0
0%
1
1.7%
1
0.8%
Not Hispanic or Latino
61
100%
58
98.3%
119
99.2%
Unknown or Not Reported
0
0%
0
0%
0
0%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
1
1.6%
0
0%
1
0.8%
Asian
2
3.3%
1
1.7%
3
2.5%
Native Hawaiian or Other Pacific Islander
0
0%
0
0%
0
0%
Black or African American
2
3.3%
6
10.2%
8
6.7%
White
55
90.2%
52
88.1%
107
89.2%
More than one race
1
1.6%
0
0%
1
0.8%
Unknown or Not Reported
0
0%
0
0%
0
0%
Region of Enrollment (participants) [Number]
United States
61
100%
59
100%
120
100%

Outcome Measures

1. Primary Outcome
Title Adherence to Dietary Goals
Description Percentage of participants who met 70% of diet goals as outlined in the exchange list
Time Frame 6 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title 1 Healthy Eating 2 Mediterranean
Arm/Group Description Healthy People 2010 Diet Healthy People 2010 Diet through dietary counseling: 6 months telephone counseling Mediterranean Diet Mediterranean Diet through dietary counseling: 6 months telephone counseling
Measure Participants 61 59
Number [percentage of participants meeting goals]
89
145.9%
85
144.1%

Adverse Events

Time Frame 5 years
Adverse Event Reporting Description
Arm/Group Title 1 Healthy Eating 2 Mediterranean
Arm/Group Description Healthy People 2010 Diet Healthy People 2010 Diet through dietary counseling: 6 months telephone counseling Mediterranean Diet Mediterranean Diet through dietary counseling: 6 months telephone counseling
All Cause Mortality
1 Healthy Eating 2 Mediterranean
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
1 Healthy Eating 2 Mediterranean
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/61 (0%) 2/59 (3.4%)
Gastrointestinal disorders
surgery 0/61 (0%) 0 1/59 (1.7%) 1
Psychiatric disorders
bipolar relapse 0/61 (0%) 0 1/59 (1.7%) 1
Other (Not Including Serious) Adverse Events
1 Healthy Eating 2 Mediterranean
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 15/61 (24.6%) 18/59 (30.5%)
Infections and infestations
various minor conditions 15/61 (24.6%) 15 18/59 (30.5%) 18

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Zora Djuric
Organization University of Michigan
Phone 734-615-6210
Email zoralong@umich.edu
Responsible Party:
Zora Djuric, Research Professor, University of Michigan
ClinicalTrials.gov Identifier:
NCT00475722
Other Study ID Numbers:
  • HUM00007622
First Posted:
May 21, 2007
Last Update Posted:
Sep 26, 2016
Last Verified:
Aug 1, 2016